These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9414330)
21. [Clinical significance of the use-dependent sodium channel block and reverse use-dependent potassium channel block of class I and class III antiarrhythmic agents and their values to predict drug efficacy]. Sadanaga T; Ogawa S; Okada Y; Handa S Jpn Circ J; 1992; 56 Suppl 5():1474-6. PubMed ID: 1337923 [No Abstract] [Full Text] [Related]
22. [Pharmacology and clinical biopharmacy of quinidine]. Huynh-Ngoc T; Sirois G J Pharm Belg; 1974 Mar; 29(2):152-80. PubMed ID: 4840388 [No Abstract] [Full Text] [Related]
23. [Can atrial fibrillation be managed without anti-arrhythmia drugs?]. Blanc JJ; Mansourati J Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126 [TBL] [Abstract][Full Text] [Related]
24. Supraventricular arrhythmias--digoxin and quinidine revisited. Ong ML; Jackson G Br J Clin Pract; 1985 Jun; 39(6):219, 234. PubMed ID: 4041346 [No Abstract] [Full Text] [Related]
25. [Antifibrillatory properties of new alkoxynaphthoic acid-esters in comparison with quinidine and procaine amide]. Igarashi T; Hashimoto N Arzneimittelforschung; 1968 Oct; 18(10):1274-8. PubMed ID: 5755706 [No Abstract] [Full Text] [Related]
26. [Drug therapy of pre-excitation syndromes]. Puletti M; Curione M G Ital Cardiol; 1977 Aug; 7(8):809-15. PubMed ID: 21121 [No Abstract] [Full Text] [Related]
27. Treatment of ventricular arrhythmias in the failing heart: pharmacologic and clinical considerations. Woosley RL; Echt DS; Roden DM Ration Drug Ther; 1985 Oct; 19(10):1-7. PubMed ID: 4070623 [No Abstract] [Full Text] [Related]
29. Early and late results of conversion of atrial fibrillation with quinidine. A clinical and hemodynamic study. Cramér G Acta Med Scand Suppl; 1968; 490():5-102. PubMed ID: 5253729 [No Abstract] [Full Text] [Related]
30. [Mechanisms of interactions of anti-arrhythmia agents during their combined use]. Adnan Abdalla ; Mazur NA; Shestakova NV Kardiologiia; 1991 Feb; 31(2):87-91. PubMed ID: 2041300 [No Abstract] [Full Text] [Related]
32. Quinidine: a valuable medication joins the list of 'endangered species'. Viskin S; Antzelevitch C; Márquez MF; Belhassen B Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793 [No Abstract] [Full Text] [Related]
33. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine. Lin JC; Quasny HA Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570 [TBL] [Abstract][Full Text] [Related]
34. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation. Veloso HH; de Paola AA J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626 [No Abstract] [Full Text] [Related]
35. Cardiac arrhythmias. Rationale of drug therapy. Chung EK Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402 [No Abstract] [Full Text] [Related]